marketinsider

Attention Shareholders: Pomerantz Law Firm Reminds Investors of Upcoming Deadlines for Class Action Lawsuit Against Elanco Animal Health Incorporated

Attention Shareholders: Pomerantz Law Firm Reminds Investors of Upcoming Deadlines for Class Action Lawsuit Against Elanco Animal Health Incorporated Overview NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE:ELAN) and certain officers. The…

Read More

Mark Your Calendars: Sodexo’s 2024 Shareholders Meeting – Don’t Miss Out on the Preparatory Documents!

Mark Your Calendars: Sodexo’s 2024 Shareholders Meeting – Don’t Miss Out on the Preparatory Documents! Regulated Information DECEMBER 17, 2024 SODEXO COMBINED SHAREHOLDERS MEETING Availability of the preparatory documents Participating in the meeting Issy-les-Moulineaux, November 26, 2024 The Combined Annual Shareholders Meeting of Sodexo will be held on Tuesday, December 17, 2024 at 3:30 pm…

Read More

Unveiling NBPE’s October Monthly NAV Estimate: A Charming, Engaging, and Reader-Friendly Announcement!

Charmingly Eccentric: A Look into NB Private Equity Partners NAV Highlights 26 November 2024 – NB Private Equity Partners (NBPE), the $1.3bn FTSE 250 listed private equity investment company managed by Neuberger Berman, announces its 31 October 2024 monthly NAV estimate. The NAV per share was $27.31 (£21.24), resulting in a total return of (0.2%)…

Read More

Unlocking the Truth Behind Bitcoin’s Soaring Funding Rates: A Sign of a Leveraged Bull Market?

Understanding Bitcoin’s Perpetual Futures Funding Rate The Basics Bitcoin’s perpetual futures funding rate represents the cost traders incur to maintain long or short positions in the perpetual swaps market. Fees for funding rates shift between buyers and sellers based on market conditions. Positive funding rates indicate that long positions dominate, reflecting a bullish sentiment in…

Read More

Breaking News: Natera Found Guilty of False Advertising and Unfair Competition in Attempt to Harm Guardant Health’s Colorectal Cancer Test, Guardant Reveal

Guardant Health Secures One of the Largest False Advertising Verdicts in History A Victory for Colorectal Cancer Patients Guardant Health, a leading precision oncology company, has emerged victorious in a landmark legal battle against Natera, a competitor in the same space. The jury in the U.S. District Court for the Northern District of California unanimously…

Read More